Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELVN is expected to report earnings to rise 8.76% to -50 cents per share on May 08

Enliven Therapeutics ELVN Stock Earnings Reports

Q1'25

Est.

$-0.50

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.14

Q1'24

Est.

$-0.54

The last earnings report on March 13 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 15.89K shares outstanding, the current market capitalization sits at 880.61M.

View a ticker or compare two or three

Compare

ELVN